Meet Certara at EANM 2026

Certara is pleased to be participating in EANM 2026, where our experts will share the latest advancements in model-informed approaches for therapeutic radiopharmaceutical development.

Whether you’re looking to optimize dose selection, strengthen your clinical development strategy, or discuss the application of quantitative science in theranostics, we’d welcome the opportunity to connect during the meeting.

Poster presentations

Quantitative Systems Pharmacology Modeling of Targeted Radiotherapies to Predict Absorbed Dose, Inform Next Generation Design, and Improve Therapeutic Index

Authors: Joshuaine Grant, Ben Lang, Jamie Nosbisch, Amandine Manon, Diane-Charlotte Imbs, and Sarah Minucci

A Semi-mechanistic Population Biodistribution Model of 89Zr-TLX250-Px for the Diagnosis of Clear Cell Renal Cell Carcinoma

Authors: Hunter Stephens and Mirjam Trame, in collaboration with Telix

専門チームのご紹介

Connect with Certara’s experts at EANM to discuss how integrated modeling, simulation, and regulatory science can help advance your radiopharmaceutical development program. From candidate selection and first-in-human studies to dose optimization, clinical development, and regulatory submissions, our multidisciplinary team provides quantitative strategies that support confident decision-making at every stage.

Whether you’re developing diagnostic or therapeutic radiopharmaceuticals, we’d welcome the opportunity to discuss your specific challenges and explore practical, science-driven solutions tailored to your program.

Submit the form to request a meeting with our experts during EANM and someone from our team will reach out to schedule.

FAQs

Where can I meet Certara at EANM 2026?

Certara’s experts will be attending EANM 2026 in Vienna and are available to meet throughout the conference. Use the form on this page to request a meeting.

Will Certara be presenting at EANM 2026?

はい、対応しています。Certara has two accepted scientific posters highlighting quantitative approaches to therapeutic radiopharmaceutical development, including quantitative systems pharmacology (QSP) and population biodistribution modeling.

Who should meet with Certara at EANM?

We welcome conversations with pharmaceutical, biotechnology, and radiopharmaceutical professionals involved in clinical pharmacology, translational medicine, pharmacometrics, quantitative systems pharmacology (QSP), dosimetry, regulatory strategy, and therapeutic radiopharmaceutical development.

What can I discuss with Certara at EANM?

Our experts can discuss dose optimization, first-in-human dose selection, pharmacometrics, quantitative systems pharmacology (QSP), biologically effective dose (BED), regulatory strategy, and model-informed drug development for therapeutic radiopharmaceutical programs.

“"Certara's integrated quantitative approach helped us make more informed development decisions by bringing together clinical pharmacology, modeling, and regulatory expertise."”